JNJ
26
2
V
66
-2
QRVO
81
7
OKE
71
-3
SJM
33
9
DGX
46
-2
KMI
46
-2
APD
32
3
WRK
59
3
NTAP
65
4
RRC
76
-2
PRGO
66
9
ADP
58
-4
T
41
2
SRE
52
2
HST
49
-3
GS
78
2
ROP
54
-6
APH
73
2
AAL
32
-4
JNJ
26
2
V
66
-2
QRVO
81
7
OKE
71
-3
SJM
33
9
DGX
46
-2
KMI
46
-2
APD
32
3
WRK
59
3
NTAP
65
4
RRC
76
-2
PRGO
66
9
ADP
58
-4
T
41
2
SRE
52
2
HST
49
-3
GS
78
2
ROP
54
-6
APH
73
2
AAL
32
-4
Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.
Sell
38

CRSP
CRISPR Therapeutics AG

Last Price:
53.90
Seasonality Move:
22.82%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.

CRISPR Therapeutics AG Price Quote

$53.90
-0.01 (0.32%)
(Updated: April 27, 2024 at 5:59 AM ET)

CRISPR Therapeutics AG Key Stats

Sell
38
CRISPR Therapeutics AG (CRSP) is a Sell
Day range:
$52.81 - $54.94
52-week range:
$37.55 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.43%
Volume:
1.3M
Avg. volume:
1.3M
1-year change:
10.81%
Market cap:
$4.6B
Revenue:
$370M
EPS:
$-1.93

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Is CRISPR Therapeutics AG Cash Flow Positive?

  • What Is CRSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$260.4M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $62.7M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $374.6M

CRISPR Therapeutics AG Return On Invested Capital

  • Is Management Doing A Good Job?
    CRSP return on invested capital is -8.39%
  • What Is CRISPR Therapeutics AG Return On Assets?
    ROA measures how assets are converting to revenues and is -6.98%
  • What Is CRSP Return On Equity?
    ROE is a measure of profitability and is -8.39%

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

Data Unavailable

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2212.87%
Revenue: 3333233.33% 63.47%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 88.13
Upside from Last Price: 63.47%

Major Shareholders

  • How many CRSP shares are owned by institutional investors?
    92.5M CRSP shares are owned by institutional investors
  • How many CRSP shares are owned by insiders?
    1.6M CRSP shares are owned by insiders